InvestorsHub Logo
Followers 321
Posts 31925
Boards Moderated 22
Alias Born 12/30/2004

Re: None

Thursday, 01/25/2024 12:32:16 PM

Thursday, January 25, 2024 12:32:16 PM

Post# of 113226
CNXC -15 to 88, looks oversold. Nov Q4 earnings beat estimates, but guidance for Q1 and 2024 was mildly disappointing. It's now trading at a forward PE of merely 7.3 based on FY24 adj EPS guidance of $12.10 midpoint. For FY23 they posted adj EPS of 11.45. Concentrix is a business services company.

briefing -

Concentrix beats by $0.29, beats on revs; guides Q1 EPS below consensus, revs below consensus; guides FY24 EPS below consensus, revs below consensus (103.90 -0.54) :
Reports Q4 (Nov) earnings of $3.36 per share, excluding non-recurring items, $0.29 better than the FactSet Consensus of $3.07; revenues rose 36.0% year/year to $2.23 bln vs the $2.2 bln FactSet Consensus.
Co issues downside guidance for Q1 (Feb), sees EPS of $2.51-2.65, excluding non-recurring items, vs. $3.17 FactSet Consensus; sees Q1 revs of $2.360-2.406 bln vs. $2.45 bln FactSet Consensus.
Co issues downside guidance for FY24, sees EPS of $11.69-12.50, excluding non-recurring items, vs. $12.81 FactSet Consensus; sees FY24 revs of $9.51-9.70 bln vs. $9.8 bln FactSet Consensus.

For chart technicians, there's a notable gap in the low $80's from back in November that might get filled ....

I picked up a small starter position this morning.

https://ir.concentrix.com/news-releases/news-release-details/concentrix-reports-fiscal-2023-fourth-quarter-and-full-year

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.